H.C. Wainwright Downgrades Apellis Pharmaceuticals (APLS) to Neutral

April 1, 2026 6:06 AM

H.C. Wainwright analyst Douglas Tsao downgraded Apellis Pharmaceuticals (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found